Profile and prevalence of HBV among HIV affected individuals attending the largest public HIV care center in India
暂无分享,去创建一个
R. Prabu | V. Selvaraj | C. Chandrasekar | K. Raja | C. G. Girish Kumar | A. Valan | S. Koli | J. Suria Kumar
[1] R. Prabu,et al. Profile and prevalence of HBV among HIV affected individuals attending the largest public HIV care center in India , 2016, VirusDisease.
[2] P. Puri. Tackling the Hepatitis B Disease Burden in India. , 2014, Journal of clinical and experimental hepatology.
[3] Ajit Kumar,et al. Hepatitis B and/or C co-infection in HIV infected patients: A study in a tertiary care centre from south India , 2013, The Indian journal of medical research.
[4] S. Chakrabarti,et al. Influence of HIV-associated degree of immune suppression on molecular heterogeneity of hepatitis B virus among HIV co-infected patients. , 2013, Virology.
[5] B. Gazzard,et al. Increasing burden of liver disease in patients with HIV infection , 2011, The Lancet.
[6] Sarman Singh,et al. Occult Hepatitis B Virus infection in ART-Naive HIV-Infected Patients seen at a Tertiary Care Centre in North India , 2010, BMC infectious diseases.
[7] C. Leen,et al. British HIV Association guidelines for the management of coinfection with HIV‐1 and hepatitis B or C virus 2010 , 2010, HIV medicine.
[8] C. Thio,et al. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] G. Chander,et al. Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV‐infected clinical cohort , 2009, HIV medicine.
[10] M. Kumar,et al. Epidemiology, Screening, and Natural History of Chronic Hepatitis B Infection , 2009 .
[11] J. Kao,et al. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] S. Thyagarajan,et al. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. , 2007, World journal of gastroenterology.
[13] M. Johnson,et al. Predictors and kinetics of occult hepatitis B virus infection in HIV‐infected persons , 2007, Journal of medical virology.
[14] Y. Benhamou. Hepatitis B in the HIV-Coinfected Patient , 2007, Journal of acquired immune deficiency syndromes.
[15] S. Swaminathan,et al. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function. , 2006, Journal of postgraduate medicine.
[16] J. Rockstroh. Influence of viral hepatitis on HIV infection. , 2006, Journal of hepatology.
[17] Tankhiwale Ss,et al. Seroprevalence of anti-HCV and hepatitis B surface antigen in HIV infected patients. , 2003 .
[18] S. Tankhiwale,et al. Seroprevalence of anti-HCV and hepatitis B surface antigen in HIV infected patients. , 2003, Indian journal of medical microbiology.
[19] A. Albanese,et al. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. , 1998, American journal of respiratory and critical care medicine.
[20] D. Solomon,et al. Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients. , 1979, JAMA.